Literature DB >> 1868247

Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial.

E A Rachmilewitz, A Goldfarb, G Dover.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1868247

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Low doses of rHuEPO administered to adult patients with thalassemia intermedia.

Authors:  F Dore; E Gaviano; S Bonfigli; S Pardini; P Pistidda; L Guiso; M Longinotti
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

2.  Serum erythropoietin levels in thalassemia intermedia.

Authors:  F Dore; S Bonfigli; E Gaviano; S Pardini; P Cianciulli; G Papa; M Longinotti
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

Review 3.  Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications.

Authors:  A Markham; H M Bryson
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

4.  Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts.

Authors:  N Naffakh; A Henri; J L Villeval; P Rouyer-Fessard; P Moullier; N Blumenfeld; O Danos; W Vainchenker; J M Heard; Y Beuzard
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

5.  Involvement of phosphatases in proliferation, maturation, and hemoglobinization of developing erythroid cells.

Authors:  Eitan Fibach
Journal:  J Signal Transduct       Date:  2011-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.